Latest United Kingdom News

Nick Scali expects first-half FY27 underlying net profit of $28 million to $32 million after a sharp slowdown in Australia and New Zealand. The UK business is growing strongly, but ANZ revenue is forecast to fall 11% to 14% and the company has booked almost $1 million in cyber incident costs.

Boresight Ltd (ASX: BST) used its first quarter after listing to build inventory, expand its US manufacturing footprint and prepare for a larger military order, despite unaudited revenue of about A$829,000. Cash stood at A$5.39 million with no debt after operating outflows of A$2.28 million.

Algorae has secured exclusive Australian commercial rights across eight Umedica-branded molecules while separately advancing a Umedica-supplied product towards regulatory approval. The broader arrangement remains partly non-binding, with financial terms undisclosed and TGA approval still pending.

Zoono Group has advanced retailer, packaging and shipping-container programs across several markets, but ended the September quarter with just NZ$77,000 in cash. The company estimates funding for 0.67 quarters and says further funding lines or an equity raise may be required if customer receipts do not accelerate.

Austco Healthcare is pursuing its largest acquisition to date, combining a real-time monitoring software business with an aged care nurse call specialist in a deal worth up to an estimated $19.3 million. The transactions would add debt, recurring revenue and integration risk as the company expands beyond its core Tacera platform.

ARB Corporation’s FY26 profit fell 5.2% as weaker Australian aftermarket and OEM sales outweighed modest export growth. The 4x4 accessories maker is relying on improved vehicle supply, US expansion and new product programs to rebuild momentum in FY27.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

ECS Botanics is taking six Australian-grown medicinal cannabis flower products into the UK through Curaleaf Laboratories, with initial supply targeted for November. The two-year deal offers access to UK sell-through but no guaranteed volumes, revenue or minimum purchases.

Unity Metals has opened a non-renounceable share purchase plan targeting $1 million to fund gold and copper-gold exploration in Cambodia and Thailand. Eligible shareholders can buy shares at a 15.2% discount, with attaching options subject to a later shareholder vote.

Kelsian Group has completed the $149.9 million sale of its Tourism Portfolio to Journey Beyond, reducing pro forma leverage to approximately 2.0x. The transport operator has reset FY27 Underlying EBITDA guidance to $295 million-$310 million as it shifts towards commuter and contracted services.

Cann Group’s FY2026 profit was transformed by a one-off A$55.7 million debt-forgiveness gain, while a leaner cost base and new export sales offered more durable progress. The company remains loss-making on a normalised basis and dependent on lender waivers and a future refinancing.

TradeWindow is targeting 13% to 18% revenue growth in FY27 and expects to approach EBITDA breakeven, while preparing to shift its primary listing from the NZX to the ASX. The freight software company also reported rising recurring revenue, stronger customer economics and NZ$4.0 million in cash at 30 June 2026.